Clinical Trials Browser

Phase 1 × Colonic Neoplasms × TNFSF10 protein, human × Clear all

NCT00873756 2016-11-02

A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms